MS

Biogen’s Best-Selling Drug Loses Patent In EU, Says Cowen
Investors.com
Fri, 03/11/16 - 09:37 am
Biogen
patents
Europe
Tecfidera
MS
multiple sclerosis
New rivals, formulary squeeze pose a double threat to Biogen MS sales
Fierce Pharma
Mon, 03/7/16 - 10:04 pm
Biogen
formulary
MS
multiple sclerosis
Roche
ocrelizumab
Tecfidera
New drug for severe form of MS generates glimmer of hope — and tempered expectations
Stat
Fri, 02/19/16 - 10:07 am
MS
multiple sclerosis
Roche
ocrelizumab
Roche looks ahead to immuno-oncology, MS to back up big-selling cancer meds
Fierce Pharma
Fri, 01/29/16 - 08:23 pm
Roche
MS
multiple sclerosis
immuno-oncology
Sanofi Chipping Away At Biogen's MS Dominance
Investors.com
Mon, 11/30/15 - 06:45 pm
Sanofi
Biogen
MS
multiple sclerosis
Aubagio
Tecfidera
Did Roche Unleash Biogen's Worst Nightmare?
Motley Fool
Tue, 10/20/15 - 05:55 pm
Roche
Biogen
MS
multiple sclerosis
ocrelizumab
Roche drug may set new benchmark in MS, data suggest
Yahoo/Reuters
Thu, 10/8/15 - 12:31 pm
Roche
multiple sclerosis
MS
ocrelizumab
Genzyme is not calling its newest MS drug a 'cure', but it looks like one in most patients
Bizjournals.com
Thu, 10/8/15 - 09:10 am
Genzyme
MS
Lemtrada
multiple sclerosis
Roche poised for MS coup with PhIII success in progressive disease
Fierce Pharma
Thu, 10/1/15 - 05:27 pm
MS
multiple sclerosis
Roche
ocrelizumab
FDA approves Bayer's autoinjector for MS drug
BioPharma Dive
Mon, 09/28/15 - 06:14 pm
FDA
Bayer
MS
multiple sclerosis
Betaseron
Betaconnect
Roche preps for make-or-break MS data with eyes on a crowded space
Fierce Biotech
Thu, 09/17/15 - 05:19 pm
Roche
MS
multiple sclerosis
ocrelizumab
Bad news for Biogen: Tecfidera sales trend flat in Q3, analyst says
Fierce Pharma Marketing
Wed, 09/16/15 - 10:00 am
Biogen
Tecfidera
MS
multiple sclerosis
Why is Novartis' Copaxone copy lagging? It's all about coverage, analyst explains
Fierce Pharma
Fri, 09/11/15 - 05:53 pm
Novartis
Copaxone
MS
multiple sclerosis
biosimilars
Teva
Glatopa
Merck KGaA to try again to get approval for MS pill cladribine
Yahoo/Reuters
Fri, 09/11/15 - 09:57 am
Merck
KGaA
MS
multiple sclerosis
cladribine
Analysts at Merrill Lynch believe Mylan’s patent challenge will not have a negative impact on Teva
Bidness, ETC
Fri, 08/28/15 - 08:02 am
Mylan Labs
Teva Pharmaceutical
patents
generics
Copaxone
MS
multiple sclerosis
U.S. patent office puts new Copaxone's IP shield under the lens
Fierce Pharma
Wed, 08/26/15 - 08:28 pm
patents
intellectual property
Copaxone
MS
multiple sclerosis
Hedge fund manager Kyle Bass loses first challenges to pharma patents
Yahoo/Reuters
Tue, 08/25/15 - 08:37 am
patents
AMPYRA
Kyle Bass
Acorda Therapeutics
MS
multiple sclerosis
Novartis snaps up MS indication for Glaxo's Arzerra
BioPharma Dive
Mon, 08/24/15 - 11:38 am
Novartis
MS
multiple sclerosis
GSK
Arzerra
GlaxoSmithKline flips an MS project to Novartis for up to $1B
Fierce Biotech
Fri, 08/21/15 - 09:29 am
GSK
Novartis
MS
multiple sclerosis
ofatumumab
Trials to Test Pot-Infused Chewing Gum for MS Sufferers
Yahoo
Wed, 08/19/15 - 09:10 am
MS
multiple sclerosis
Medical Marijuana
AXIM Biotech
MedChew

Pages